DRUG POLICY ALLIANCE for DRUG POLICY ALLIANCE
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Issues related to marijuana-related policy in federal appropriations. Issues related to treatment provided in criminal justice settings and related policy in federal appropriations. Issues related to funding for harm reduction and treatment in federal appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL COLLINS | — |
| MICHAEL LISZEWSKI New | — |
Law Enforcement/Crime/Criminal Justice LAW
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| QUEEN ABIMBOLA ADESUYI | — |
| MICHAEL COLLINS | — |
| GRANT SMITH | — |
Health Issues HCR
HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL COLLINS | — |
| GRANT SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.